Lemnisca develops AI-native digital twin technology to make biomanufacturing predictable and scalable, assisting companies from R&D to commercial production by bridging the gap between biological innovation and industrial manufacturing.
Lemnisca is a biotechnology company that builds AI-native digital twins, referred to as flight simulators, to make biomanufacturing more predictable and scalable. Their platform integrates wet-lab experimental data with AI-ML models that are grounded by the principles of metabolism and reactor physics. This approach supports researchers and manufacturers by facilitating virtual experimentation, providing guidance during the scale-up process, and offering real-time manufacturing support to maintain stable production outcomes. By bridging the gap between innovation and industrial reality, the company aims to democratize the use of biology as a manufacturing engine for the circular economy. The technology addresses common industry challenges such as productivity failures in R&D, performance drops during scale-up, and process drifting in commercial manufacturing settings.